UMPS1 Antibody

What is UMPS and what role does it play in cellular metabolism?

UMPS (uridine monophosphate synthetase) is a critical enzyme in pyrimidine synthesis, specifically responsible for converting orotic acid to uridine 5′ monophosphate. This enzyme represents a key step in the de novo pyrimidine biosynthetic pathway, making it essential for cellular proliferation and nucleic acid synthesis. UMPS exists in multiple isoforms with molecular weights of approximately 53 kDa, 43 kDa, 33 kDa, and 23 kDa, enabling diverse functionality in different cellular contexts . Understanding UMPS function is particularly relevant in cancer research, where pyrimidine metabolism is often dysregulated.

What are the validated applications for UMPS antibodies in research?

UMPS antibodies have been validated for multiple laboratory applications with specific recommended dilutions for optimal results. For Western Blot (WB) applications, dilutions of 1:500-1:2000 have shown specific detection in multiple cell lines including HeLa, Jurkat, HEK-293T, and COLO 320 . For Immunoprecipitation (IP), 0.5-4.0 μg of antibody per 1.0-3.0 mg of total protein lysate is recommended, with positive detection confirmed in HEK-293 cells . Immunohistochemistry (IHC) applications require dilutions of 1:20-1:200, with validated detection in human colon cancer tissue . Published literature demonstrates successful applications in knockdown/knockout validation studies, further confirming the specificity and utility of these antibodies in research settings.

What are the proper storage and handling conditions for maintaining UMPS antibody activity?

For optimal performance and longevity, UMPS antibodies should be stored at -20°C in their provided buffer (PBS with 0.02% sodium azide and 50% glycerol, pH 7.3) . Under these conditions, antibodies remain stable for one year after shipment. Unlike many antibodies, aliquoting is unnecessary for -20°C storage, which simplifies laboratory protocols . For the 20 μl product size, solutions contain 0.1% BSA as a stabilizer. Repeated freeze-thaw cycles should be avoided to prevent degradation of antibody performance. When handling, use sterile technique and avoid contamination, particularly when returning unused portions to storage.

How can I optimize UMPS antibody performance in challenging tissue samples?

Optimization of UMPS antibody performance in challenging tissues requires careful consideration of antigen retrieval methods. For formalin-fixed paraffin-embedded (FFPE) tissues, heat-induced epitope retrieval (HIER) using TE buffer at pH 9.0 is specifically recommended for UMPS antibody applications . In cases where this proves insufficient, alternative antigen retrieval using citrate buffer at pH 6.0 may yield improved results . Additionally, extending primary antibody incubation time (overnight at 4°C) can enhance signal in tissues with low UMPS expression. Blocking protocols should be optimized using 5-10% normal serum from the same species as the secondary antibody. For particularly challenging samples, signal amplification systems such as tyramide signal amplification may be employed to enhance detection sensitivity while maintaining specificity.

What approaches should I use to validate UMPS antibody specificity in my experimental system?

Comprehensive validation of UMPS antibody specificity requires multiple complementary approaches. First, include positive controls (tissues or cells known to express UMPS) and negative controls (UMPS-knockout samples or isotype controls) in your experiments . Western blot analysis should confirm bands at the expected molecular weights (52 kDa and 45 kDa for the primary isoforms) . For definitive validation, perform siRNA or CRISPR-based knockdown/knockout of UMPS and demonstrate corresponding reduction in antibody signal. This approach has been utilized in published literature for UMPS antibody validation . Additionally, testing reactivity across species boundaries (the antibody shows confirmed reactivity with human and mouse samples) can further support specificity claims . Pre-adsorption tests using purified UMPS protein can determine if the observed signal is specifically blocked by the target antigen.

How can I adapt methodologies for dual immunofluorescence studies with UMPS antibodies?

For dual immunofluorescence studies involving UMPS antibodies, careful selection of compatible primary antibodies from different host species is essential. Since UMPS antibody (14830-1-AP) is raised in rabbit, pair it with mouse, goat, or rat-derived antibodies against other targets of interest. To minimize cross-reactivity, use highly cross-adsorbed secondary antibodies with species-specific reactivity. Sequential staining protocols may be necessary when antibodies require different fixation or antigen retrieval conditions. Begin with the more sensitive antibody (often the UMPS antibody) and proceed to the more robust one. Optimal dilutions for immunofluorescence applications typically range from 1:50-1:200, requiring empirical determination for specific tissue types . Include appropriate controls for autofluorescence and implement spectral unmixing when fluorophore emission spectra overlap.

What are the most common causes of inconsistent UMPS antibody staining in IHC, and how can they be addressed?

Inconsistent UMPS antibody staining in IHC can result from several factors that require systematic troubleshooting. Fixation variables are often critical - overfixation can mask epitopes while underfixation may compromise tissue morphology. For UMPS detection, optimize fixation time (typically 24-48 hours in 10% neutral buffered formalin) and ensure proper tissue penetration. Antigen retrieval is particularly important for UMPS detection, with TE buffer at pH 9.0 specifically recommended; insufficient retrieval represents a common cause of weak or absent staining . Antibody concentration must be empirically determined for each tissue type, starting with the recommended range of 1:20-1:200 . Additionally, endogenous peroxidase or phosphatase activity may generate false positives if blocking steps are inadequate. For UMPS detection in colon cancer tissue, extended blocking (30-60 minutes) with hydrogen peroxide followed by protein blocking is recommended. Finally, secondary antibody cross-reactivity can be eliminated by using highly adsorbed detection reagents.

Why might I observe multiple bands in Western blot analysis with UMPS antibody, and how should I interpret them?

Multiple bands in Western blot analysis using UMPS antibody reflect both technical and biological factors requiring careful interpretation. UMPS is known to exist in multiple isoforms, with expected molecular weights of 52 kDa and 45 kDa most commonly observed in Western blot applications . Additionally, UMPS has documented isoforms of 33 kDa and 23 kDa that may appear depending on the tissue or cell type being analyzed . Bands at unexpected molecular weights should be evaluated for:

• Post-translational modifications - phosphorylation, glycosylation, or ubiquitination can alter apparent molecular weight

• Proteolytic processing - incomplete protease inhibition during sample preparation

• Alternative splicing - tissue-specific expression of different UMPS transcripts

• Non-specific binding - particularly in complex lysates

To determine specificity, compare observed band patterns with positive control lysates from HeLa, Jurkat, HEK-293T, or COLO 320 cells, where UMPS expression has been validated . Consider performing peptide competition assays or analyzing UMPS-knockout samples to confirm band specificity.

How can I address cross-reactivity issues when detecting UMPS in multi-species studies?

Addressing cross-reactivity in multi-species studies requires careful antibody selection and validation. While the UMPS antibody (14830-1-AP) has confirmed reactivity with both human and mouse samples , variations in epitope conservation across more distant species may affect binding affinity and specificity. When extending studies to other species, begin with sequence alignment analysis of the immunogen region (UMPS fusion protein Ag6620) across target species to predict potential cross-reactivity . Empirical validation is essential, beginning with Western blot analysis of tissue lysates from each species to confirm the expected band pattern (primarily 52 kDa and 45 kDa) . For definitive validation in new species, consider using UMPS-knockout tissues or cells as negative controls. If cross-reactivity issues persist, epitope mapping and pre-adsorption with recombinant proteins from the species of interest can help identify the specific regions recognized by the antibody. Alternatively, adaptation of detection protocols with species-specific secondary antibodies and optimized blocking conditions (using serum from the secondary antibody host species) may reduce non-specific signals.

How can I implement mass spectrometry-based approaches to confirm UMPS antibody specificity and characterize binding epitopes?

Implementing mass spectrometry for UMPS antibody validation and epitope characterization involves several advanced methodological approaches. Begin with immunoprecipitation using the UMPS antibody (recommended: 0.5-4.0 μg antibody per 1.0-3.0 mg protein lysate) followed by SDS-PAGE separation . Excise bands corresponding to expected UMPS molecular weights (52 kDa and 45 kDa) for tryptic digestion and LC-MS/MS analysis . The resulting peptide sequences can be matched against the UMPS protein sequence (UniProt ID: P11172) to confirm identity . For epitope mapping, implement hydrogen-deuterium exchange mass spectrometry (HDX-MS) by comparing deuterium incorporation patterns of free UMPS protein versus antibody-bound UMPS. Regions protected from deuterium exchange in the antibody-bound state correspond to the binding epitope. Advanced de novo sequencing algorithms, such as those in the updated Stitch v1.5 platform, can help resolve sequence ambiguities arising from isobaric residues (leucine/isoleucine) and incomplete fragmentation spectra . The mass-based alignment algorithms in these tools explicitly account for mass coincidence errors, improving epitope characterization accuracy .

What are the considerations for using UMPS antibodies in studying cancer metabolism and drug resistance mechanisms?

UMPS plays a critical role in pyrimidine synthesis pathways frequently dysregulated in cancer, making UMPS antibodies valuable tools in cancer metabolism research. When designing studies to investigate UMPS in cancer contexts, consider that UMPS expression has been validated in several cancer cell lines including HeLa and COLO 320 . These cell lines serve as appropriate positive controls. For tissue studies, human colon cancer tissue has demonstrated specific UMPS immunoreactivity using recommended IHC protocols (1:20-1:200 dilution with TE buffer pH 9.0 for antigen retrieval) . When investigating drug resistance mechanisms, particularly for antimetabolite therapies targeting pyrimidine synthesis (5-fluorouracil, capecitabine), quantitative analysis of UMPS expression by Western blot can correlate enzyme levels with treatment response. For such applications, standard curve generation using recombinant UMPS protein is recommended for accurate quantification. Multi-parametric analysis combining UMPS immunostaining with markers of proliferation (Ki-67) or nucleotide metabolism (TK1, RRM2) can provide mechanistic insights into metabolic adaptations driving resistance. When analyzing patient-derived samples, consider potential heterogeneity in UMPS expression, necessitating multiple sampling regions and careful statistical analysis.

How should I approach optimization of multiplex immunofluorescence panels incorporating UMPS antibodies for spatial biology applications?

Optimizing multiplex immunofluorescence panels with UMPS antibodies requires systematic panel design and validation. Begin with antibody selection, choosing markers with biological relevance to UMPS function in pyrimidine metabolism. Since UMPS antibody (14830-1-AP) is a rabbit polyclonal , pair it with primary antibodies from different species (mouse, goat, rat) to enable species-specific secondary detection. For each antibody in the panel:

• Validate singleplex performance before multiplexing

• Determine optimal concentration through titration experiments

• Establish appropriate antigen retrieval conditions (for UMPS: TE buffer pH 9.0)

• Select fluorophores with minimal spectral overlap

For sequential staining approaches, implement antibody stripping or quenching between rounds, validating complete removal of previous antibodies. Alternatively, employ tyramide signal amplification (TSA) which allows multiple rabbit antibodies to be used sequentially after stripping. For spatial biology applications, include region-specific controls (e.g., normal adjacent tissue) alongside tumor samples. Image acquisition requires careful exposure settings to avoid saturation while maintaining signal detection. Automated image analysis using machine learning algorithms can help quantify UMPS expression patterns across tissue regions, correlating with other markers to establish spatial relationships between pyrimidine metabolism and cellular phenotypes.

How can UMPS antibodies be utilized in studying the relationship between pyrimidine metabolism and immune cell function?

Utilizing UMPS antibodies to investigate connections between pyrimidine metabolism and immune function requires specialized experimental approaches. Begin with immunophenotyping experiments combining UMPS detection with lineage-specific immune markers in flow cytometry or multiplexed immunohistochemistry. For flow cytometry applications with UMPS antibody, implement protocols similar to those validated for other intracellular metabolic enzymes, using appropriate fixation and permeabilization buffers . When analyzing tissue sections, coordinate UMPS staining (using recommended dilutions of 1:20-1:200) with immune cell markers to assess spatial relationships between UMPS-expressing cells and immune infiltrates. For functional studies, isolate specific immune cell populations (T cells, B cells, macrophages) and analyze UMPS expression during activation, proliferation, or differentiation using Western blot analysis (1:500-1:2000 dilution) . To establish causal relationships, implement UMPS inhibition (pharmacological or genetic) followed by comprehensive immunophenotyping and functional assays (cytokine production, proliferation). This approach can reveal how pyrimidine metabolism constraints affect immune cell function, particularly in rapidly proliferating lymphocytes where nucleotide demands are high.

What are the technical considerations for adapting UMPS antibodies for super-resolution microscopy applications?

Adapting UMPS antibodies for super-resolution microscopy requires specialized sample preparation and detection strategies to achieve nanoscale resolution. For structured illumination microscopy (SIM) or stimulated emission depletion (STED) microscopy, conventional immunofluorescence protocols can be adapted using the UMPS antibody at optimized concentrations (typically higher than standard immunofluorescence, starting with 1:10-1:50 dilutions) . For single-molecule localization methods (STORM/PALM), consider direct conjugation of the UMPS antibody with photoswitchable fluorophores to minimize the distance between target and fluorophore. Sample preparation becomes critical - use thin sections (≤10 μm) with optimized fixation (2-4% paraformaldehyde for 10-20 minutes) to preserve ultrastructure while maintaining epitope accessibility. The documented reactivity with human and mouse samples provides flexibility in model system selection . For multicolor applications, pair the UMPS antibody with other targets relevant to pyrimidine metabolism, ensuring appropriate controls for chromatic aberration correction. Quantitative analysis of UMPS nanoscale distribution requires specialized algorithms for cluster analysis and colocalization at super-resolution scales, with careful consideration of resolution-dependent statistical methods.

How can I implement UMPS antibodies in studies of metabolic reprogramming during cellular stress responses?

Implementing UMPS antibodies to investigate metabolic reprogramming during stress requires integrated experimental designs combining expression analysis with functional metabolic assays. Begin by establishing baseline UMPS expression in your model system using Western blot analysis at recommended dilutions (1:500-1:2000) . Then expose cells to relevant stressors (hypoxia, nutrient deprivation, oxidative stress) and assess UMPS expression changes temporally, correlating with functional measurements of pyrimidine metabolism. For mechanistic studies, combine UMPS immunoprecipitation (using 0.5-4.0 μg antibody per 1.0-3.0 mg lysate) with mass spectrometry to identify stress-induced protein-protein interactions that may regulate enzyme activity. Subcellular localization changes during stress can be monitored using immunofluorescence with appropriate organelle markers. To establish functional significance, implement metabolic flux analysis using isotope-labeled precursors (13C-glucose, 15N-glutamine) before and after stress induction, correlating metabolic outputs with UMPS expression and localization changes. This integrative approach can reveal how pyrimidine metabolism adaptation contributes to cellular stress responses, particularly in cancer cells where metabolic plasticity promotes survival under adverse conditions.